These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2284719)

  • 1. [Changes in hemostasis in blood donors on the Fenwal CS 3000 separator].
    Pittrová H; Koza V; Cepelák V; Vít L
    Vnitr Lek; 1990 Dec; 36(12):1197-202. PubMed ID: 2284719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of plateletpheresis with two different cell separators using 100 identical donors.
    Wiesneth M; Freudenberg J; Platow S; Kalinova J; Vogel M; Kubanek B
    Beitr Infusionsther; 1991; 28():201-3. PubMed ID: 1725619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thrombopheresis with the CS-3000 cell separator. Changes in primary hemostasis in the donor and in concentrates in 8-day storage].
    Budde U
    Beitr Infusionther Klin Ernahr; 1986; 15():75-81. PubMed ID: 3092802
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of plateletpheresis on complete blood count values using three different cell separator systems in healthy donors.
    Beyan C; Cetin T; Kaptan K; Nevruz O
    Transfus Apher Sci; 2003 Aug; 29(1):45-7. PubMed ID: 12877892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of the centrifugation speed on the sedimentation behavior of thrombocytes in the CS-3000 Cell Separator (Fenwal)].
    Brauer H; Aulmann HM; Stangel W
    Beitr Infusionther Klin Ernahr; 1987; 18():219-22. PubMed ID: 3439977
    [No Abstract]   [Full Text] [Related]  

  • 6. Donors leukapheresis on Fenwal CS-3000.
    Kotelba-Witkowska B; Mrowiec ZR; Daszyński J; Skrzeczkowska E
    Mater Med Pol; 1990; 22(1):33-5. PubMed ID: 2079859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Fenwal Amicus blood cell separator in double dose platelet collection.
    Gürak S; Arslan O
    Transfus Apher Sci; 2007 Feb; 36(1):69-72. PubMed ID: 17270496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to stabilize the level of ionized calcium and citrate during plateletpheresis.
    Farrokhi P; Farahmand H; Bismuth A; Suarez C; Ducot B; Gillon MC; Debat P; Laskowski P; Pinon F
    Vox Sang; 1998; 74(1):7-12. PubMed ID: 9481853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thrombocytapheresis with the new PLT-30 collection chamber in the CS 3000 Plus cell separator].
    Moog R; Müller N
    Beitr Infusionsther Transfusionsmed; 1994; 32():323-4. PubMed ID: 9480118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing yield of plateletpheresis using intermittent flow cell separator.
    DAS SS; Chaudhary RK; Shukla JS
    Clin Lab Haematol; 2005 Oct; 27(5):316-9. PubMed ID: 16178912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thrombocyte aggregate formation during thrombocyte concentrate preparation with the CS-3000 Cell Separator (Fenwal) and its effects on the analysis of the concentrate with the Coulter Counter S Plus IV].
    Wassmann A; Aulmann HM; Stangel W; Meinicke K
    Beitr Infusionther Klin Ernahr; 1987; 18():216-8. PubMed ID: 3439976
    [No Abstract]   [Full Text] [Related]  

  • 12. White blood cell depletion of single-donor platelet preparations using the new adsorption filter biofil P 10 BBS.
    Müller N
    Beitr Infusionsther Transfusionsmed; 1994; 32():55-7. PubMed ID: 9422101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of the isoradial chamber in the preparation of thrombocyte concentrates using the Travenol CS-3000 separator].
    Bláha M; Jebavý L; Malý J; Siroký O
    Cas Lek Cesk; 1989 Oct; 128(42):1336-7. PubMed ID: 2598246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of Fenwal CS-3000 plateletpheresis performed at a rapid donor blood flow rate: rapid plateletpheresis with Fenwal CS-3000.
    Strauss RG; Ludwig GA; Randels MJ; Winegarden DC
    J Clin Apher; 1991; 6(1):21-3. PubMed ID: 2045378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Which are the parameters to be controlled in platelet concentrates in order that they may be offered to the medical profession as a standardized product with specific properties?
    Vox Sang; 1981 Feb; 40(2):115-26. PubMed ID: 7233883
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of plateletpheresis on blood coagulation parameters in healthy donors at National Blood Centre, Kuala Lumpur, Malaysia.
    Siti Nadiah AK; Nor Asiah M; Nur Syimah AT; Normi M; Anza E; Aini AN; Mohd Zahari TH; Shahnaz M; Faraizah AK; Faisal MA
    Transfus Apher Sci; 2013 Dec; 49(3):507-10. PubMed ID: 24055412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Psychophysiological thrombocyte changes in cell-separator donors].
    Aulmann HM; Baltrusch HJ; Stangel W; Waltz EM
    Beitr Infusionther Klin Ernahr; 1987; 18():227-9. PubMed ID: 3439979
    [No Abstract]   [Full Text] [Related]  

  • 18. [Initial experiences with routine use of the AS-104 cell separator in a single needle procedure].
    Zeiler T; Weisbach V; Zingsem J; Zimmermann R; Eckstein R
    Beitr Infusionsther; 1993; 31():100-3. PubMed ID: 7693235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Haemonetics MCS-3 pump system: improved production quality in thrombocytapheresis with a discontinuous cell separator].
    Pawlow I; Richter E; Matthes G; Rath E; Tofoté U
    Beitr Infusionsther Transfusionsmed; 1994; 32():325-7. PubMed ID: 9480119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet apheresis affects prothrombin time and plasminogen levels in healthy donors.
    Beyan C; Kaptan K; Savaşçi S; Ifran A; Oztürk Y; Okmen B
    Transfus Apher Sci; 2005 Aug; 33(1):47-50. PubMed ID: 15953764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.